NTH — Naturhouse Health SA Cashflow Statement
0.000.00%
Last trade - 00:00- €109.41m
- €90.78m
- €49.43m
- 95
- 62
- 44
- 80
Annual cashflow statement for Naturhouse Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 13.5 | 18.2 | 13.1 | 15.4 | 13.5 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -2.86 | -0.234 | 0.371 | 0.169 | -0.207 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.65 | -4.29 | -8.68 | 3.1 | -3.73 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 14.6 | 16.2 | 7.1 | 20.9 | 11.6 |
| Capital Expenditures | -0.201 | -0.05 | -0.964 | -0.57 | -0.338 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.313 | -4.22 | -4.25 | 0.111 | 1.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.112 | -4.27 | -5.22 | -0.459 | 0.862 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.39 | -6.27 | -17 | -7.7 | -16.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.3 | 5.64 | -15.1 | 12.3 | -3.71 |